nach oben

Archives of Dermatological Research

Erschienen in:

01.05.2015 | Review

Geographic variations in epidemiology of two autoimmune bullous diseases: pemphigus and bullous pemphigoid

verfasst von: Erkan Alpsoy, Ayse Akman-Karakas, Soner Uzun

Erschienen in: Archives of Dermatological Research | Ausgabe 4/2015

Einloggen, um Zugang zu erhalten

Abstract

Autoimmune bullous diseases are rare, organ-specific, a group of blistering disease of skin and mucous membranes. Recent studies suggest that the frequency of the autoimmune bullous diseases has been increasing. Pemphigus vulgaris and bullous pemphigoid are the most frequently reported autoimmune bullous diseases. High incidence of autoimmune bullous diseases in some ethnic groups such as pemphigus in Ashkenazi Jewish, or in some regions such as pemphigus foliaceus in Brazil has been shown to be related to genetic and environmental factors, respectively. Pemphigus has been reported more frequently in the female gender. Although it is most frequently diagnosed between the ages 50 and 60 in European countries, in the remaining countries in the world, it is seen between the ages of 30 and 50. Bullous pemphigoid is generally seen above 70 years of age. Although overall incidence is slightly higher in females, after the age of 80 years it is more frequent in males. Both pemphigus vulgaris and bullous pemphigoid has a chronic course with recurrences. Mortality risk of the patients with bullous pemphigoid was found at least 2 times higher and the mortality risk of the patients with pemphigus was found approximately 3 times higher than that of the general population. In this review, the results obtained from the epidemiological studies were analyzed according to geographic regions, and especially epidemiologic features of two prevalent autoimmune bullous diseases, pemphigus and bullous pemphigoid have been discussed.

Aboobaker J, Morar N, Ramdial PK, Hammond MG (2001) Pemphigus in South Africa. Int J Dermatol 40:115–119CrossRefPubMed

Adam BA (1992) Bullous diseases in Malaysia: epidemiology and natural history. Int J Dermatol 31:42–45CrossRefPubMed

Ahmed AR, Wagner R, Khatri K et al (1991) Major histocompatibility complex haplotypes and class II genes in non-Jewish patients with pemphigus vulgaris. Proc Natl Acad Sci USA 88:5056–5060CrossRefPubMedCentralPubMed

Ahmed AR, Yunis EJ, Khatri K et al (1990) Major histocompatibility complex haplotype studies in Ashkenazi Jewish patients with pemphigus vulgaris. Proc Natl Acad Sci USA 87:7658–7662CrossRefPubMedCentralPubMed

Akman A, Kacaroglu H, Yilmaz E et al (2008) Periodontal status in patients with pemphigus vulgaris. Oral Dis 14:640–643CrossRefPubMed

Amin MN, Islam AZ (2006) Clinical, histologic and immunologic features of pemphigus in Bangladesh. Int J Dermatol 45:1317–1318CrossRefPubMed

Baican A, Baican C, Chiriac G et al (2010) Pemphigus vulgaris is the most common autoimmune bullous disease in Northwestern Romania. Int J Dermatol 49:768–774PubMed

Bastuji-Garin S, Joly P, Lemordant P et al (2011) Risk factors for bullous pemphigoid in the elderly: a prospective case-control study. J Invest Dermatol 131:637–643CrossRefPubMed

Bastuji-Garin S, Joly P, Picard-Dahan C et al (1996) Drugs associated with bullous pemphigoid. a case-control study. Arch Dermatol 132:272–276CrossRefPubMed

10.

Bastuji-Garin S, Souissi R, Blum L et al (1995) Comparative epidemiology of pemphigus in Tunisia and France: unusual incidence of pemphigus foliaceus in young Tunisian women. J Invest Dermatol 104:302–305CrossRefPubMed

11.

Benchikhi H, Ghafour S, Disky A et al (2008) Pemphigus: analysis of 262 cases. Int J Dermatol 47:973–975CrossRefPubMed

12.

Bernard P, Vaillant L, Labeille B et al (1995) Incidence and distribution of subepidermal autoimmune bullous skin diseases in three French regions. Bullous Diseases French Study Group. Arch Dermatol 131:48–52CrossRefPubMed

13.

Bertram F, Bröcker EB, Zillikens D et al (2009) Prospective analysis of the incidence of autoimmune bullous disorders in Lower Franconia, Germany. J Dtsch Dermatol Ges 7:434–440PubMed

14.

Bourdon-Lanoy E, Roujeau JC, Joly P et al (2005) Bullous pemphigoid in young patients: a retrospective study of 74 cases. Ann Dermatol Venereol 132:115–122CrossRefPubMed

15.

Brenner S, Tur E, Shapiro J (2001) Pemphigus vulgaris: environmental factors. Occupational, behavioral, medical, and qualitative food frequency questionnaire. Int J Dermatol 40:562–569CrossRefPubMed

16.

Chams-Davatchi C, Valikhani M, Daneshpazhooh M et al (2005) Pemphigus: analysis of 1209 cases. Int J Dermatol 44:470–476CrossRefPubMed

17.

Colbert RL, Allen DM, Eastwood D et al (2004) Mortality rate of bullous pemphigoid in a US medical center. J Invest Dermatol 122:1091–1095CrossRefPubMed

18.

Cozzani E, Parodi A, Rebora A et al (2001) Gruppo Ligure di Studi in Dermatologia (GLISID). Bullous pemphigoid in Liguria: a 2-year survey. J Eur Acad Dermatol Venereol 15:317–319PubMed

19.

Culton DA, Qian Y, Li N et al (2008) Advances in pemphigus and its endemic pemphigus foliaceus (Fogo Selvagem) phenotype: a paradigm of human autoimmunity. J Autoimmun 31:311–324CrossRefPubMedCentralPubMed

20.

Daneshpazhooh M, Chams-Davatchi C, Payandemehr P et al (2012) Spectrum of autoimmune bullous diseases in Iran: a 10-year review. Int J Dermatol 51:35–41CrossRefPubMed

21.

Delgado JC, Hameed A, Yunis JJ et al (1997) Pemphigus vulgaris autoantibody response is linked to HLA-DQB1*0503 in Pakistani patients. Hum Immunol 57:110–119CrossRefPubMed

22.

Delgado JC, Turbay D, Yunis EJ et al (1996) A common major histocompatibility complex class II allele HLA-DQB1* 0301 is present in clinical variants of pemphigoid. Proc Natl Acad Sci USA 6(93):8569–8571CrossRef

23.

Delgado JC, Yunis DE, Bozon MV et al (1996) MHC class II alleles and haplotypes in patients with pemphigus vulgaris from India. Tissue Antigens 48:668–672CrossRefPubMed

24.

Diaz LA, Glamb RW, Silva J Jr (1980) A syndrome of multiple immune autoreactivity. A breakdown in immune regulation. Arch Dermatol 116:77–79CrossRefPubMed

25.

Firooz A, Mazhar A, Ahmed AR (1994) Prevalence of autoimmune diseases in the family members of patients with pemphigus vulgaris. J Am Acad Dermatol 31(3 Pt 1):434–437CrossRefPubMed

26.

Golusin Z, Poljacki M, Jovanovic M et al (2005) Some epidemiological features of pemphigus chronicus in South Vojvodina: a 12-year retrospective study. Int J Dermatol 44:792–793CrossRefPubMed

27.

Gudi VS, White MI, Cruickshank N et al (2005) Annual incidence and mortality of bullous pemphigoid in the Grampian Region of North-east Scotland. Br J Dermatol 153:424–427CrossRefPubMed

28.

Hahn-Ristic K, Rzany B, Amagai M et al (2002) Increased incidence of pemphigus vulgaris in southern Europeans living in Germany compared with native Germans. J Eur Acad Dermatol Venereol 16:68–71CrossRefPubMed

29.

Hietanen J, Salo OP (1982) Pemphigus: an epidemiological study of patients treated in Finnish hospitals between 969 and 1978. Acta Derm Venereol 62:491–496PubMed

30.

Huang YH, Kuo CF, Chen YH et al (2012) Incidence, mortality, and causes of death of patients with pemphigus in Taiwan: a Nationwide Population-Based Study. J Invest Dermatol 132:92–97CrossRefPubMed

31.

Huh WK, Tada J, Fujimoto W et al (2001) Thyroid gland tumour, pemphigus foliaceus and myasthenia gravis in the daughter of a woman with myasthenia gravis. Clin Exp Dermatol 26:504–506CrossRefPubMed

32.

Jin P, Shao C, Ye G (1993) Chronic bullous dermatoses in China. Int J Dermatol 32:89–92CrossRefPubMed

33.

Joly P, Baricault S, Sparsa A et al (2012) Incidence and mortality of bullous pemphigoid in France. J Invest Dermatol 132:1998–2004CrossRefPubMed

34.

Jung M, Kippes W, Messer G et al (1999) Increased risk of bullous pemphigoid in male and very old patients: a population-based study on incidence. J Am Acad Dermatol 41:266–268CrossRefPubMed

35.

Kaya Koc C, Sallakci N, Akman-Karakaş A et al (2013) HLA class I and class II antigens in the patients with pemphigus in Southern Turkey. Int J Dermatol 52:53–58CrossRef

36.

Krain LS, Terasaki PI, Newcomer VD et al (1973) Increased frequency of HLA-A10 in pemphigus vulgaris. Arch Dermatol 108:803–805CrossRefPubMed

37.

Kumar KA (2008) Incidence of pemphigus in Thrissur district, south India. Indian J Dermatol Venereol Leprol 74:349–351CrossRefPubMed

38.

Langan SM, Smeeth L, Hubbard R et al (2008) Bullous pemphigoid and pemphigus vulgaris–incidence and mortality in the UK: population based cohort study. BMJ 337:a180CrossRefPubMedCentralPubMed

39.

Lee JJ, Downham TF (2006) Furosemide-induced bullous pemphigoid. Case report and review of literature. J Drugs Dermatol 5:562–564PubMed

40.

Leshem YA, Katzenelson V, Yosipovitch G, David M, Mimouni D (2011) Autoimmune diseases in patients with pemphigus and their first-degree relatives. Int J Dermatol 50:827–831CrossRefPubMed

41.

Lindelöf B, Islam N, Eklund G et al (1990) Pemphigoid and cancer. Arch Dermatol 126:66–68CrossRefPubMed

42.

Lo Schiavo A, Ruocco E, Brancaccio G et al (2013) Bullous pemphigoid: etiology, pathogenesis, and inducing factors: Facts and controversies. Clin Dermatol 31:391–399CrossRefPubMed

43.

Mahé A, Flageul B, Cissé I et al (1996) Pemphigus in Mali: a study of 30 cases. Br J Dermatol 134:114–119CrossRefPubMed

44.

Marazza G, Pham HC, Schärer L et al (2009) Incidence of bullous pemphigoid and pemphigus in Switzerland: a 2-year prospective study. Br J Dermatol 161:861–868CrossRefPubMed

45.

Meyer N, Misery L (2010) Geoepidemiologic considerations of auto-immune pemphigus. Autoimmun Rev 9:A379–A382CrossRefPubMed

46.

Micali G, Musumeci ML, Nasca MR (1998) Epidemiologic analysis and clinical course of 84 consecutive cases of pemphigus in eastern Sicily. Int J Dermatol 37:197–200CrossRefPubMed

47.

Michailidou EZ, Belazi MA, Markopoulos AK et al (2007) Epidemiologic survey of pemphigus vulgaris with oral manifestations in northern Greece: retrospective study of 129 patients. Int J Dermatol 46:356–361CrossRefPubMed

48.

Mimouni D, Bar H, Gdalevich M et al (2008) Pemphigus-analysis of epidemiological factors in 155 patients. J Eur Acad Dermatol Venereol 22:1232–1235CrossRefPubMed

49.

Nanda A, Dvorak R, Al-Saeed K et al (2004) Spectrum of autoimmune bullous diseases in Kuwait. Int J Dermatol 43:876–881CrossRefPubMed

50.

Okazaki A, Miyagawa S, Yamashina Y, Kitamura W, Shirai T (2000) Polymorphisms of HLA-DR and -DQ genes in Japanese patients with bullous pemphigoid. J Dermatol 27:149–156CrossRefPubMed

51.

Ong E, Goldacre R, Hoang U et al (2014) Associations between bullous pemphigoid and primary malignant cancers: an English national record linkage study, 1999–2011. Arch Dermatol Res 306:75–80CrossRefPubMed

52.

Park MS, Terasaki PI, Ahmed AR et al (1979) HLA-DRW4 in 91% of pemphigus vulgaris patients. Lancet 2:441–442CrossRefPubMed

53.

Pisanti S, Sharav Y, Kaufman E et al (1974) Pemphigus vulgaris: incidence in Jews of different ethnic groups, according to age, sex, and initial lesion. Oral Surg Oral Med Oral Pathol 38:382–387CrossRefPubMed

54.

Roujeau JC, Lok C, Bastuji-Garin S et al (1998) High risk of death in elderly patients with extensive bullous pemphigoid. Arch Dermatol 134:465–469CrossRefPubMed

55.

Ruocco V, Ruocco E, Lo Schiavo A et al (2013) Pemphigus: etiology, pathogenesis, and inducing or triggering factors: facts and controversies. Clin Dermatol 31:374–381CrossRefPubMed

56.

Salmanpour R, Shahkar H, Namazi MR et al (2006) Epidemiology of pemphigus in south-western Iran: a 10-year retrospective study (1991–2000). Int J Dermatol 45:103–105CrossRefPubMed

57.

Serwin AB, Bokiniec E, Piascik M et al (2007) Epidemiological and clinical analysis of pemphigoid patients in northeastern Poland in 2000-2005. Med Sci Monit 13:360–364

58.

Simon DG, Krutchkoff D, Kaslow RA et al (1980) Pemphigus in Hartford County, Connecticut, from 1972 to 1977. Arch Dermatol 116:1035–1037CrossRefPubMed

59.

Sullivan TP, Elgart GW, Kirsner RS (2002) Pemphigus and smoking. Int J Dermatol 41:528–530CrossRefPubMed

60.

Tallab T, Joharji H, Bahamdan K et al (2001) The incidence of pemphigus in the southern region of Saudi Arabia. Int J Dermatol 40:570–572CrossRefPubMed

61.

Tsankov N, Vassileva S, Kamarashev J et al (2000) Epidemiology of pemphigus in Sofia, Bulgaria. A 16-year retrospective study (1980–1995). Int J Dermatol 39:104–108CrossRefPubMed

62.

Uzun S, Durdu M, Akman A et al (2006) Pemphigus in the mediterranean region of Turkey: a study of 148 cases. Int J Dermatol 45:523–528CrossRefPubMed

63.

Vega-Memije ME, Saez de Ocariz-Gutierrez MM, Corte-Franco R et al (2001) Analysis of HLA-DR in Mexican patients with pemphigus. Gac Med Mex 137:535–540PubMed

64.

Venning VA, Wojnarowska F (1995) Induced bullous pemphigoid. Br J Dermatol 132:831–832CrossRefPubMed

65.

V’lckova-Laskoska MT, Laskoski DS, Kamberova S et al (2007) Epidemiology of pemphigus in Macedonia: a 15-year retrospective study (1990–2004). Int J Dermatol 46:253–258CrossRefPubMed

66.

Waisbourd-Zinman O, Ben-Amitai D, Cohen AD et al (2008) Bullous pemphigoid in infancy: clinical and epidemiologic characteristics. J Am Acad Dermatol 58:41–48CrossRefPubMed

67.

Wong SN, Chua SH (2002) Spectrum of subepidermal immunobullous disorders seen at the National Skin Centre, Singapore: a 2-year review. Br J Dermatol 147:476–480CrossRefPubMed

68.

Zakka LR, Reche P, Ahmed AR (2011) Role of MHC Class II genes in the pathogenesis of pemphigoid. Autoimmun Rev 11:40–47CrossRefPubMed

69.

Zaraa I, Kerkeni N, Ishak F et al (2011) Spectrum of autoimmune blistering dermatoses in Tunisia: an 11-year study and a review of the literature. Int J Dermatol 50:939–944CrossRefPubMed

70.

Zillikens D, Wever S, Roth A et al (1995) Incidence of autoimmune subepidermal blistering dermatoses in a region in central Germany. Arch Dermatol 131:957–958CrossRefPubMed

Titel: Geographic variations in epidemiology of two autoimmune bullous diseases: pemphigus and bullous pemphigoid
verfasst von: Erkan Alpsoy
Ayse Akman-Karakas
Soner Uzun
Publikationsdatum: 01.05.2015
Verlag: Springer Berlin Heidelberg
Erschienen in: Archives of Dermatological Research / Ausgabe 4/2015
Print ISSN: 0340-3696
Elektronische ISSN: 1432-069X
DOI: https://doi.org/10.1007/s00403-014-1531-1

Leitlinien kompakt für die Dermatologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Dermatologie

Riesenzellarteriitis: 15% der Patienten sind von okkulter Form betroffen

16.05.2024 Riesenzellarteriitis Nachrichten

In einer retrospektiven Untersuchung haben Forschende aus Belgien und den Niederlanden die okkulte Form der Riesenzellarteriitis genauer unter die Lupe genommen. In puncto Therapie und Rezidivraten stellten sie keinen sehr großen Unterschied zu Erkrankten mit kranialen Symptomen fest.

Betalaktam-Allergie: praxisnahes Vorgehen beim Delabeling

16.05.2024 Pädiatrische Allergologie Nachrichten

Die große Mehrheit der vermeintlichen Penicillinallergien sind keine. Da das „Etikett“ Betalaktam-Allergie oft schon in der Kindheit erworben wird, kann ein frühzeitiges Delabeling lebenslange Vorteile bringen. Ein Team von Pädiaterinnen und Pädiatern aus Kanada stellt vor, wie sie dabei vorgehen.

Isotretinoin: Risiko für schwere Laboranomalien „marginal erhöht“

08.05.2024 Akne Nachrichten

Die Aknetherapie mit Isotretinoin kann einen Anstieg von Leberenzymen und Blutfetten verursachen. Das Risiko für schwere Störungen ist laut einer Forschungsgruppe der Universität Lübeck aber nur marginal erhöht und auf einen engen Zeitraum konzentriert.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Update Dermatologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2015

YAP immunoreactivity is directly related to pilomatrixoma size and proliferation rate

Study of T helper 1 and T helper 2 responses in pemphigus vulgaris patients receiving interferon alpha 2a injections in addition to a standard protocol therapy: a randomized controlled trial

The activation of cultured keratinocytes by cholesterol depletion during reconstruction of a human epidermis is reminiscent of monolayer cultures

Apocytolysis, a proposed mechanism of blister formation in epidermolysis bullosa simplex

Regulation of immune cells in oral lichen planus